Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia Jonathan M. MeyerChristoph U. Correll Leading Article Open access 20 July 2023 Pages: 545 - 570
The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression Alexander L. W. SmithCatherine J. HarmerSusannah E. Murphy Review Article 29 June 2023 Pages: 571 - 585
BRAF Mutations in CNS Tumors—Prognostic Markers and Therapeutic Targets Thiago P. MunizWarren P. Mason Review Article 02 June 2023 Pages: 587 - 598
Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System Guadalupe DávilaMaría José Torres-PriorisMarcelo L. Berthier Review Article Open access 21 June 2023 Pages: 599 - 637
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem Tobias Di MarcoThomas E. ScammellYves Dauvilliers Original Research Article Open access 21 July 2023 Pages: 639 - 653
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder Maxwell Z. PriceRichard L. Price Original Research Article Open access 10 July 2023 Pages: 655 - 660
Correction to: Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine Hannah A. Blair Correction Open access 04 July 2023 Pages: 661 - 661